Barclays’s Tabula Rasa HealthCare, Inc. Common Stock TRHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-224,778
Closed -$2.32M 5435
2023
Q3
$2.32M Buy
+224,778
New +$2.13M ﹤0.01% 1801
2022
Q2
Sell
-3,765
Closed -$23K 5373
2022
Q1
$23K Sell
3,765
-25,686
-87% -$231K ﹤0.01% 4411
2021
Q4
$442K Buy
29,451
+10,130
+52% +$184K ﹤0.01% 3260
2021
Q3
$506K Buy
19,321
+6,993
+57% +$258K ﹤0.01% 3193
2021
Q2
$617K Sell
12,328
-14,647
-54% -$655K ﹤0.01% 2951
2021
Q1
$1.24M Buy
26,975
+2,916
+12% +$139K ﹤0.01% 2644
2020
Q4
$1.03M Sell
24,059
-14,810
-38% -$562K ﹤0.01% 2737
2020
Q3
$1.58M Buy
38,869
+16,952
+77% +$844K ﹤0.01% 2298
2020
Q2
$1.2M Buy
21,917
+2,067
+10% +$118K ﹤0.01% 2592
2020
Q1
$1.04M Sell
19,850
-13,975
-41% -$757K ﹤0.01% 2907
2019
Q4
$1.65M Buy
33,825
+12,630
+60% +$591K ﹤0.01% 3198
2019
Q3
$1.16M Sell
21,195
-399
-2% -$22.8K ﹤0.01% 3514
2019
Q2
$1.08M Buy
21,594
+8,413
+64% +$419K ﹤0.01% 3603
2019
Q1
$744K Buy
13,181
+5,216
+65% +$311K ﹤0.01% 3731
2018
Q4
$508K Sell
7,965
-16,920
-68% -$1.2M ﹤0.01% 3809
2018
Q3
$2.02M Buy
24,885
+11,888
+91% +$871K ﹤0.01% 2869
2018
Q2
$830K Buy
12,997
+6,378
+96% +$313K ﹤0.01% 3479
2018
Q1
$257K Sell
6,619
-933
-12% -$32.7K ﹤0.01% 4605
2017
Q4
$212K Buy
7,552
+7,335
+3,380% +$215K ﹤0.01% 4647
2017
Q3
$6K Buy
217
+122
+128% +$2.33K ﹤0.01% 6371
2017
Q2
$1K Buy
95
+69
+265% +$931 ﹤0.01% 6556
2017
Q1
$0 Buy
+26
New +$373 ﹤0.01% 7056

Other funds holding TRHC

Barclays's TRHC Position: Q4 2023 in Review

Barclays sold out of Tabula Rasa HealthCare, Inc. Common Stock (TRHC) in Q4 2023, closing a stake of 224,778 shares — an estimated $2.32M sold.

Barclays first reported a position in TRHC in Q1 2017 and held it in 22 quarters. The position peaked at $2.32M in Q3 2023. 1 fund tracked by Wall St. Rank holds TRHC as of Q4 2023.

  • Barclays reported no remaining Tabula Rasa HealthCare, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Barclays sold 224,778 Tabula Rasa HealthCare, Inc. Common Stock shares in Q4 2023, an estimated $2.32M.
  • Barclays first reported a position in Tabula Rasa HealthCare, Inc. Common Stock in Q1 2017 and held it in 22 quarters.
  • Barclays's Tabula Rasa HealthCare, Inc. Common Stock position peaked at $2.32M in Q3 2023.
  • 1 fund tracked by Wall St. Rank held Tabula Rasa HealthCare, Inc. Common Stock as of Q4 2023.

Based on Barclays's 13F filing for Q4 2023, filed 15 Feb 2024.